As we mark the second anniversary of the Hamas attack of Oct. 7, 2023, we will mourn the victims of Hamas’ barbarism that day. We will pray and remember. We will petition for the release of the ...
Judge said no evidence to support claims of kickbacks on Harvoni, Sovaldi Whistleblower will appeal, his lawyers say Gilead settled claims of kickbacks on HIV drugs earlier this year Sept 12 (Reuters) ...
While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV business, the company this week triumphed over a whistleblower lawsuit ...
Steve Buscemi explains that everyone has been pronouncing his name wrong, but that even he isn't quite sure how to say it. During a recent interview, the 67-year-old actor discussed the many ways he ...
Gilead Sciences broke ground on its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters in California. This milestone ...
(KRON) — Gilead Sciences announced on Wednesday it was breaking ground on a new pharmaceutical and manufacturing hub at its Foster City headquarters. The development is part of the company’s $32 ...
GameSpot may get a commission from retail offers. Despite the legendary dragon Pokemon's popularity, a large number of Pokemon fans are going around pronouncing Rayquaza's name wrong--and The Pokemon ...
Gilead Sciences (NASDAQ:GILD) announced its second-quarter 2025 earnings and revised annual outlook after the market closed on Thursday. The HIV drug maker reported adjusted earnings of $2.01 per ...
Gilead Sciences has returned the rights to a cancer candidate it licensed from Arcus Biosciences in a $725 million, multiprogram deal, confirming its retreat from an asset that was deprioritized ...
Needham upgraded Gilead stock to buy today. The analyst sees billion-dollar potential in Gilead's Yeztugo drug for preventing HIV. Gilead stock looked cheap before the upgrade. It could be an even ...
How Gilead is helping innovate HIV prevention, removing stigma and empowering Black women. By Spenser Mestel This story was created in paid partnership with Gilead Sciences. Pre-exposure prophylaxis ...
Journal Editorial Report: RFK Jr's new picks play into his critics’ hands. Good news the world can use: The Food and Drug Administration last week approved Gilead Science’s twice-a-year shot that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results